Raras
Buscar doenças, sintomas, genes...
Sequência de deformação de acinesia fetal
ORPHA:994CID-10 · Q87.8CID-11 · LD2F.1YOMIM 208150DOENÇA RARA

Qualquer condição em que o feto apresenta um conjunto de problemas de formação e alterações físicas, causados pela falta de movimento, e cuja causa é uma alteração (mutação) no gene MUSK.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Qualquer condição em que o feto apresenta um conjunto de problemas de formação e alterações físicas, causados pela falta de movimento, e cuja causa é uma alteração (mutação) no gene MUSK.

Publicações científicas
118 artigos
Último publicado: 2026 Feb 16

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
Antenatal
+ neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q87.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

😀
Face
10 sintomas
🦴
Ossos e articulações
6 sintomas
💪
Músculos
6 sintomas
🫁
Pulmão
2 sintomas
🧠
Neurológico
2 sintomas
👂
Ouvidos
2 sintomas

+ 30 sintomas em outras categorias

Características mais comuns

100%prev.
HP:0003577
Frequência: 14/14
100%prev.
Criptorquidia
Frequente (79-30%)
100%prev.
Contratura congênita
Frequência: 5/5
100%prev.
Contratura em flexão do punho
Frequência: 12/12
100%prev.
Hipoplasia pulmonar
Muito frequente (99-80%)
90%prev.
Insuficiência respiratória
Muito frequente (99-80%)
63sintomas
Muito frequente (16)
Frequente (11)
Ocasional (9)
Muito raro (1)
Sem dados (26)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 63 características clínicas mais associadas, ordenadas por frequência.

HP:0003577
Frequência: 14/14100%
CriptorquidiaCryptorchidism
Frequente (79-30%)100%
Contratura congênitaCongenital contracture
Frequência: 5/5100%
Contratura em flexão do punhoWrist flexion contracture
Frequência: 12/12100%
Hipoplasia pulmonarPulmonary hypoplasia
Muito frequente (99-80%)100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico118PubMed
Últimos 10 anos65publicações
Pico201910 papers
Linha do tempo
2026Hoje · 2026🧪 2010Primeiro ensaio clínico📈 2019Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

10 genes identificados com associação a esta condição. Padrão de herança: Autosomal recessive.

GLDNGliomedinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Ligand for NRCAM and NFASC/neurofascin that plays a role in the formation and maintenance of the nodes of Ranvier on myelinated axons. Mediates interaction between Schwann cell microvilli and axons via its interactions with NRCAM and NFASC. Nodes of Ranvier contain clustered sodium channels that are crucial for the saltatory propagation of action potentials along myelinated axons. During development, nodes of Ranvier are formed by the fusion of two heminodes. Required for normal clustering of so

LOCALIZAÇÃO

Cell membraneCell projection, axonSecretedSecreted, extracellular space, extracellular matrix

MECANISMO DE DOENÇA

Lethal congenital contracture syndrome 11

A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy and congenital non-progressive joint contractures. The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
48.6 TPM
Brain Spinal cord cervical c-1
40.5 TPM
Artéria tibial
27.0 TPM
Substância negra
17.8 TPM
Aorta
17.2 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
lethal congenital contracture syndrome 11fetal akinesia deformation sequence 1
HGNC:29514UniProt:Q6ZMI3
MYOD1Myoblast determination protein 1Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Acts as a transcriptional activator that promotes transcription of muscle-specific target genes and plays a role in muscle differentiation. Together with MYF5 and MYOG, co-occupies muscle-specific gene promoter core region during myogenesis. Induces fibroblasts to differentiate into myoblasts. Interacts with and is inhibited by the twist protein. This interaction probably involves the basic domains of both proteins (By similarity)

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
MyogenesisTGFBR3 expression
MECANISMO DE DOENÇA

Congenital myopathy 17

An autosomal recessive muscular disorder characterized by hypotonia and respiratory insufficiency apparent soon after birth, high diaphragmatic dome on imaging, poor overall growth, pectus excavatum, dysmorphic facies, and renal anomalies in some affected individuals. Additional variable features include delayed motor development, mildly decreased endurance, distal arthrogryposis, and lung hypoplasia resulting in early death.

EXPRESSÃO TECIDUAL(Tecido-específico)
Músculo esquelético
21.7 TPM
Testículo
1.0 TPM
Cerebelo
0.2 TPM
Cérebro - Hemisfério cerebelar
0.1 TPM
Glândula salivar
0.1 TPM
OUTRAS DOENÇAS (2)
myopathy, congenital, with diaphragmatic defects, respiratory insufficiency, and dysmorphic faciesfetal akinesia deformation sequence 1
HGNC:7611UniProt:P15172
KIF21AKinesin-like protein KIF21ADisease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Processive microtubule plus-end directed motor protein involved in neuronal axon guidance. Is recruited by KANK1 to cortical microtubule stabilizing complexes (CMSCs) at focal adhesions (FAs) rims where it promotes microtubule capture and stability. Controls microtubule polymerization rate at axonal growth cones and suppresses microtubule growth without inducing microtubule disassembly once it reaches the cell cortex

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCytoplasm, cell cortexCell projection, axonCell projection, dendriteCell projection, growth cone

VIAS BIOLÓGICAS (2)
KinesinsCOPI-dependent Golgi-to-ER retrograde traffic
MECANISMO DE DOENÇA

Fibrosis of extraocular muscles, congenital, 1

A congenital ocular motility disorder marked by restrictive ophthalmoplegia affecting extraocular muscles innervated by the oculomotor and/or trochlear nerves. It is clinically characterized by anchoring of the eyes in downward gaze, ptosis, and backward tilt of the head. Patients affected by congenital fibrosis of extraocular muscles type 1 show an absence of the superior division of the oculomotor nerve (cranial nerve III) and corresponding oculomotor subnuclei.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
44.0 TPM
Cerebelo
34.5 TPM
Brain Frontal Cortex BA9
31.4 TPM
Hipotálamo
25.5 TPM
Brain Spinal cord cervical c-1
23.1 TPM
OUTRAS DOENÇAS (3)
congenital fibrosis of extraocular muscles type 1congenital fibrosis of extraocular musclesfetal akinesia deformation sequence 1
HGNC:19349UniProt:Q7Z4S6
NUP88Nuclear pore complex protein Nup88Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Component of nuclear pore complex

LOCALIZAÇÃO

Nucleus, nuclear pore complex

VIAS BIOLÓGICAS (10)
snRNP AssemblyHCMV Early EventsHCMV Late EventsNEP/NS2 Interacts with the Cellular Export MachineryTransport of Ribonucleoproteins into the Host Nucleus
MECANISMO DE DOENÇA

Fetal akinesia deformation sequence 4

A clinically and genetically heterogeneous group of disorders with congenital malformations related to impaired fetal movement. Clinical features include fetal akinesia, intrauterine growth retardation, polyhydramnios, arthrogryposis, pulmonary hypoplasia, craniofacial abnormalities, and cryptorchidism. FADS4 inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
81.2 TPM
Linfócitos
61.5 TPM
Tireoide
35.0 TPM
Fibroblastos
29.7 TPM
Músculo esquelético
29.2 TPM
OUTRAS DOENÇAS (2)
fetal akinesia deformation sequence 4fetal akinesia deformation sequence 1
HGNC:8067UniProt:Q99567
RAPSN43 kDa receptor-associated protein of the synapseDisease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Postsynaptic protein required for clustering of nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction. It may link the receptor to the underlying postsynaptic cytoskeleton, possibly by direct association with actin or spectrin

LOCALIZAÇÃO

Cell membranePostsynaptic cell membraneCytoplasm, cytoskeleton

MECANISMO DE DOENÇA

Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency

A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features are easy fatigability and muscle weakness affecting the axial and limb muscles (with hypotonia in early-onset forms), the ocular muscles (leading to ptosis and ophthalmoplegia), and the facial and bulbar musculature (affecting sucking and swallowing, and leading to dysphonia). The symptoms fluctuate and worsen with physical effort. CMS11 is an autosomal recessive disorder of postsynaptic neuromuscular transmission, due to deficiency of AChR at the endplate that results in low amplitude of the miniature endplate potential and current.

EXPRESSÃO TECIDUAL(Tecido-específico)
Músculo esquelético
43.8 TPM
Nervo tibial
4.2 TPM
Glândula adrenal
2.0 TPM
Coração - Ventrículo esquerdo
1.3 TPM
Cólon sigmoide
1.3 TPM
OUTRAS DOENÇAS (5)
fetal akinesia deformation sequence 2congenital myasthenic syndrome 11postsynaptic congenital myasthenic syndromelethal multiple pterygium syndrome
HGNC:9863UniProt:Q13702
SLC18A3Vesicular acetylcholine transporterDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Electrogenic antiporter that exchanges one cholinergic neurotransmitter, acetylcholine or choline, with two intravesicular protons across the membrane of synaptic vesicles. Uses the electrochemical proton gradient established by the V-type proton-pump ATPase to store neurotransmitters inside the vesicles prior to their release via exocytosis (By similarity) (PubMed:20225888, PubMed:8910293). Determines cholinergic vesicular quantal size at presynaptic nerve terminals in developing neuro-muscular

LOCALIZAÇÃO

Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane

VIAS BIOLÓGICAS (1)
Acetylcholine Neurotransmitter Release Cycle
MECANISMO DE DOENÇA

Myasthenic syndrome, congenital, 21, presynaptic

A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features are easy fatigability and muscle weakness. CMS21 is an autosomal recessive, pre-synaptic form characterized by ptosis, ophthalmoplegia, fatigable weakness, apneic crises, and deterioration of symptoms in cold water. Learning difficulties and left ventricular dysfunction may be present in some patients.

EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Putamen basal ganglia
4.2 TPM
Brain Caudate basal ganglia
2.6 TPM
Cólon sigmoide
1.7 TPM
Pituitária
1.6 TPM
Brain Nucleus accumbens basal ganglia
1.1 TPM
OUTRAS DOENÇAS (2)
congenital myasthenic syndrome 21fetal akinesia deformation sequence 1
HGNC:10936UniProt:Q16572
MAGEL2MAGE-like protein 2Disease-causing germline mutation(s) inDesconhecido
FUNÇÃO

Probably enhances ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases, possibly through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. Acts as a regulator of retrograde transport via its interaction with VPS35. Recruited to retromer-containing endosomes and promotes the formation of 'Lys-63'-linked polyubiquitin chains at 'Lys-220' of WASHC1 together with TRIM27, leading to promote endosomal F-actin assembly

LOCALIZAÇÃO

Early endosomeCytoplasmNucleus

MECANISMO DE DOENÇA

Schaaf-Yang syndrome

A disease characterized by clinical features of Prader-Willi syndrome, including neonatal hypotonia with poor suck, feeding problems in infancy, obesity, developmental delay, short stature, and hypogonadism. Additionally, patients manifest autism spectrum disorder. Some patients have dysmorphic facial features.

EXPRESSÃO TECIDUAL(Tecido-específico)
Hipotálamo
16.6 TPM
Pituitária
15.9 TPM
Brain Nucleus accumbens basal ganglia
8.1 TPM
Cervix Endocervix
6.5 TPM
Cervix Ectocervix
4.4 TPM
OUTRAS DOENÇAS (6)
Schaaf-Yang syndromePrader-Willi syndrome due to paternal deletion of 15q11q13 type 2fetal akinesia deformation sequence 1Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15
HGNC:6814UniProt:Q9UJ55
DOK7Protein Dok-7Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Probable muscle-intrinsic activator of MUSK that plays an essential role in neuromuscular synaptogenesis. Acts in aneural activation of MUSK and subsequent acetylcholine receptor (AchR) clustering in myotubes. Induces autophosphorylation of MUSK

LOCALIZAÇÃO

Cell membraneSynapse

MECANISMO DE DOENÇA

Myasthenic syndrome, congenital, 10

A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features are easy fatigability and muscle weakness affecting the axial and limb muscles (with hypotonia in early-onset forms), the ocular muscles (leading to ptosis and ophthalmoplegia), and the facial and bulbar musculature (affecting sucking and swallowing, and leading to dysphonia). The symptoms fluctuate and worsen with physical effort. CMS10 is an autosomal recessive, post-synaptic form characterized by a typical 'limb girdle' pattern of muscle weakness with small, simplified neuromuscular junctions but normal acetylcholine receptor and acetylcholinesterase function.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
28.4 TPM
Coração - Átrio
27.8 TPM
Cerebelo
21.0 TPM
Músculo esquelético
19.7 TPM
Cérebro - Hemisfério cerebelar
19.5 TPM
OUTRAS DOENÇAS (4)
congenital myasthenic syndrome 10fetal akinesia deformation sequence 3postsynaptic congenital myasthenic syndromefetal akinesia deformation sequence 1
HGNC:26594UniProt:Q18PE1
TUBA1ATubulin alpha-1A chainDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCytoplasm, cytoskeleton, flagellum axoneme

VIAS BIOLÓGICAS (10)
HCMV Early EventsPKR-mediated signalingGap junction assemblyAggrephagyAssembly and cell surface presentation of NMDA receptors
MECANISMO DE DOENÇA

Lissencephaly 3

A classic type lissencephaly associated with psychomotor retardation and seizures. Features include agyria or pachygyria or laminar heterotopia, severe intellectual disability, motor delay, variable presence of seizures, and abnormalities of corpus callosum, hippocampus, cerebellar vermis and brainstem.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
1761.9 TPM
Hipotálamo
655.7 TPM
Substância negra
642.6 TPM
Cérebro - Hemisfério cerebelar
562.6 TPM
Cerebelo
519.9 TPM
OUTRAS DOENÇAS (4)
lissencephaly due to TUBA1A mutationfetal akinesia deformation sequence 1tubulinopathy-associated dysgyriacongenital fibrosis of extraocular muscles
HGNC:20766UniProt:Q71U36
MUSKMuscle, skeletal receptor tyrosine-protein kinaseDisease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Receptor tyrosine kinase which plays a central role in the formation and the maintenance of the neuromuscular junction (NMJ), the synapse between the motor neuron and the skeletal muscle (PubMed:25537362). Recruitment of AGRIN by LRP4 to the MUSK signaling complex induces phosphorylation and activation of MUSK, the kinase of the complex. The activation of MUSK in myotubes regulates the formation of NMJs through the regulation of different processes including the specific expression of genes in s

LOCALIZAÇÃO

Postsynaptic cell membrane

VIAS BIOLÓGICAS (1)
ECM proteoglycans
MECANISMO DE DOENÇA

Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency

A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features are easy fatigability and muscle weakness affecting the axial and limb muscles (with hypotonia in early-onset forms), the ocular muscles (leading to ptosis and ophthalmoplegia), and the facial and bulbar musculature (affecting sucking and swallowing, and leading to dysphonia). The symptoms fluctuate and worsen with physical effort. CMS9 is a disorder of postsynaptic neuromuscular transmission, due to deficiency of AChR at the endplate that results in low amplitude of the miniature endplate potential and current.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Baixa expressão)
Intestino delgado
3.1 TPM
Bladder
1.9 TPM
Testículo
1.8 TPM
Músculo esquelético
1.7 TPM
Pulmão
1.5 TPM
OUTRAS DOENÇAS (3)
congenital myasthenic syndrome 9fetal akinesia deformation sequence 1postsynaptic congenital myasthenic syndrome
HGNC:7525UniProt:O15146

Variantes genéticas (ClinVar)

115 variantes patogênicas registradas no ClinVar.

🧬 GLDN: NM_181789.4(GLDN):c.434-17T>G ()
🧬 GLDN: NM_181789.4(GLDN):c.363+138G>T ()
🧬 GLDN: GRCh37/hg19 15q21.1-21.2(chr15:47392800-52877953)x1 ()
🧬 GLDN: NM_181789.4(GLDN):c.139dup (p.Ala47fs) ()
🧬 GLDN: NM_181789.4(GLDN):c.1143_1144del (p.Tyr382fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 2,544 variantes classificadas pelo ClinVar.

382
2162
VUS (15.0%)
Benigna (85.0%)
VARIANTES MAIS SIGNIFICATIVAS
DOK7: NM_173660.5(DOK7):c.283G>A (p.Glu95Lys) [Uncertain significance]
RAPSN: NM_005055.5(RAPSN):c.73G>T (p.Ala25Ser) [Uncertain significance]
DOK7: NM_173660.5(DOK7):c.488T>C (p.Val163Ala) [Uncertain significance]
DOK7: NM_173660.5(DOK7):c.54+31_54+33dup [Benign]
MUSK: NM_005592.4(MUSK):c.303C>T (p.Ala101=) [Likely benign]

Vias biológicas (Reactome)

63 vias biológicas associadas aos genes desta condição.

Myogenesis TGFBR3 expression COPI-dependent Golgi-to-ER retrograde traffic Kinesins ISG15 antiviral mechanism Transport of the SLBP independent Mature mRNA Transport of the SLBP Dependant Mature mRNA Transport of Mature mRNA Derived from an Intronless Transcript Transport of Mature mRNA derived from an Intron-Containing Transcript Rev-mediated nuclear export of HIV RNA Transport of Ribonucleoproteins into the Host Nucleus NS1 Mediated Effects on Host Pathways Viral Messenger RNA Synthesis NEP/NS2 Interacts with the Cellular Export Machinery Regulation of Glucokinase by Glucokinase Regulatory Protein Nuclear import of Rev protein Vpr-mediated nuclear import of PICs snRNP Assembly SUMOylation of DNA damage response and repair proteins SUMOylation of ubiquitinylation proteins Nuclear Pore Complex (NPC) Disassembly Regulation of HSF1-mediated heat shock response SUMOylation of SUMOylation proteins SUMOylation of chromatin organization proteins SUMOylation of RNA binding proteins SUMOylation of DNA replication proteins Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) tRNA processing in the nucleus HCMV Early Events HCMV Late Events SARS-CoV-2 activates/modulates innate and adaptive immune responses Acetylcholine Neurotransmitter Release Cycle Cargo recognition for clathrin-mediated endocytosis Clathrin-mediated endocytosis Translocation of SLC2A4 (GLUT4) to the plasma membrane Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane Gap junction assembly MHC class II antigen presentation Separation of Sister Chromatids Resolution of Sister Chromatid Cohesion Regulation of PLK1 Activity at G2/M Transition HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand Loss of Nlp from mitotic centrosomes Recruitment of mitotic centrosome proteins and complexes Loss of proteins required for interphase microtubule organization from the centrosome Recruitment of NuMA to mitotic centrosomes Prefoldin mediated transfer of substrate to CCT/TriC Formation of tubulin folding intermediates by CCT/TriC Post-chaperonin tubulin folding pathway Recycling pathway of L1 Hedgehog 'off' state Anchoring of the basal body to the plasma membrane Cargo trafficking to the periciliary membrane Intraflagellar transport RHO GTPases activate IQGAPs RHO GTPases Activate Formins COPI-mediated anterograde transport COPI-independent Golgi-to-ER retrograde traffic Mitotic Prometaphase The role of GTSE1 in G2/M progression after G2 checkpoint AURKA Activation by TPX2 Carboxyterminal post-translational modifications of tubulin ECM proteoglycans

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Sequência de deformação de acinesia fetal

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
66 papers (10 anos)
#1

Perinatal genetic diagnostic yield in a population of fetuses with the phenotype arthrogryposis multiplex congenita: a cohort study 2007-2021.

European journal of human genetics : EJHG2026 Feb

Arthrogryposis multiplex congenita (AMC) presents challenges for prenatal detection due to its heterogeneous etiology, onset, and phenotypical manifestations. This study aims to describe the genetic diagnostic yield in a population of fetuses with detailed phenotypic description over a 15-year period (2007-2021) at the Fetal Medicine Unit of Amsterdam UMC, the Netherlands. The fetal and neonatal phenotypes were classified into three clinical AMC Groups, with the exception that Groups 1 and 2 were combined in the prenatal classification. Group 1 involves limb involvement primarily, Group 2 includes musculoskeletal involvement plus other system anomalies, and Group 3 involves musculoskeletal involvement with central nervous system disability, lethality, fetal akinesia deformation sequence, and/or intellectual disability. The cohort consisted of 64 consecutive cases, 13 in Groups 1 + 2 and 51 in Group 3. Perinatal genetic testing occurred in all cases: prenatally in 56 of the 64 (88%), postnatally in 36 of the 64 (56%), and combined testing in 28 of the 64 cases (44%). The overall genetic diagnostic yield was 28% (18/64), and it increased over the 5-year period from 14% to 50%. Whole exome sequencing had the highest yield (41.7%). The yield per phenotype was 30.8% (4/13) for AMC Group 1 + 2 and 27.4% (14/51) for AMC Group 3. Detailed fetal phenotyping and perinatal genetic testing in all cases showed improved diagnostic yield over time, likely due to the introduction of Next-generation sequencing-based tests. The availability of stored DNA will be beneficial for future investigations since further improvements in genetic testing possibilities are expected.

#2

Whole Genome Sequence Identifies the Second Allele: An Intronic Variant in RYR1 Contributes to Early-Onset Fetal Akinesia Deformation Sequence.

Molecular syndromology2026 Feb 16

Fetal akinesia deformation sequence (FADS), a severe prenatal phenotype associated with congenital myopathies (CMs), is linked to mutations in the RYR1 gene. Although whole exome sequencing (WES) is a standard diagnostic approach, certain pathogenic variants may remain undetected. In this study, we utilized whole genome sequencing (WGS) to investigate a recurrent case of FADS with negative WES results. A couple who experienced four consecutive pregnancy losses, including two fetuses affected by FADS, underwent trio-WGS following negative WES findings. Variants were annotated using public databases and filtered according to ACMG guidelines. Functional validation of an intronic variant was conducted using RT-PCR, TA cloning, and Sanger sequencing. WGS identified two novel RYR1 compound heterozygous variants in the affected fetus: a paternally inherited in-frame mutation (c.13659+655_14172 +588delinsCTGGCGCCCCATCTCAT) located the C-terminal hotspot and a maternally inherited deep intronic variant (c.4934+25G>A). Both of them were initially classified as variant of uncertain significance. RNA studies demonstrated that this intronic variant caused a 26-bp intron retention and frameshift, leading to its reclassification as pathogenic. And according to this PM3 evidence, the in-frame mutation was reclassified as likely pathogenic. Both variants were absent from population databases and exhibited segregation with the phenotype. This study highlights the utility of WGS in diagnosing fetal anomalies with negative WES results by identifying noncoding and structural variants. The identification of novel RYR1 mutations broadens the genetic spectrum of recessive CMs and emphasizes the necessity for functional assays to accurately interpret intronic variants. WGS is recommended for cases of recurrent fetal anomalies when WES is inconclusive, although careful interpretation of variants is advised.

#3

Preemptive immunotherapy for fetal acetylcholine receptor antibody disorder (FARAD): from recurrent pregnancy losses to a healthy infant - a case report.

Neuromuscular disorders : NMD2026 Mar

Maternal antibodies against the fetal acetylcholine receptor (fAChR) can cause fetal acetylcholine receptor antibody-related disorders (FARAD), a rare but important cause of arthrogryposis multiplex congenita (AMC) and Fetal Akinesia Deformation Sequence (FADS), with recurrence rates up to 100%. Unlike genetic causes, FARAD may respond to maternal immunotherapy, yet standardized treatment protocols are lacking. We report four pregnancies in an asymptomatic mother with confirmed fAChR antibodies. After three fetal losses due to FARAD and two unsuccessful treatment attempts initiated only after sonographic abnormalities, a healthy infant was delivered in the fourth pregnancy following a pre-planned preemptive approach. Treatment, initiated at week 10 of gestation, consisted of plasmapheresis (PLEX) and subsequent weekly high-dose intravenous immunoglobulin (IVIg). Fetal serum after birth confirmed fAChR antibodies on cell-based assays (live and fixed). This case series underscores the importance of recognizing fAChR antibodies as differential diagnosis of AMC in asymptomatic mothers and of early, consistent antibody-reducing therapy to prevent FARAD-related pregnancy losses.

#4

Variant Update on ASCC1 : Characterization of the First Homozygous Missense Variant Involved in Prenatal-Onset Spinal Muscular Atrophy With Congenital Bone Fractures 2.

American journal of medical genetics. Part A2026 Mar

Spinal muscular atrophy with congenital bone fractures 2 is a rare and severe autosomal recessive neuromuscular disorder caused by pathogenic variants in ASCC1. This condition characterized by prenatal onset of severe hypotonia with fetal hypokinesia and congenital contractures results in arthrogryposis multiplex congenita, and increased incidence of prenatal fractures. To date, only truncating variants, loss of function and splicing variants have been described. Here, we report the first homozygous missense variant in ASCC1 identified prenatally in two full siblings with fetal akinesia deformation sequence. This variant affects a highly conserved residue within the RNA-ligase-like domain and leads to a nearly total absence of ASCC1 protein in muscle. This report broadens the knowledge on the pathogenesis of this disorder showing that missense variants should also be considered. It also highlights the importance of precise ultrasound examination combined with molecular genetic testing in the prenatal diagnosis of this severe neuromuscular disorder.

#5

DOK7 Gene Novel Homozygous Mutation is Related to Fetal Akinesia Deformation Sequence 3.

Journal of obstetrics and gynaecology of India2025 Apr

Fetal akinesia deformation sequence syndrome with a prevalence of 1 per 13:000 refers to a clinically and genetically heterogeneous disorder recognized by joint contractures, pterygia, fetal hydrops, dysmorphic features and lung hypoplasia's common features. Both genetic and parental/external environmental factors can result in this syndrome. DOK7 mutations will result in Fetal akinesia deformation sequence 3; the inheritance pattern of the named gene is AR and its protein has a major role as a signaling molecule necessary for neuromuscular junction. In this study, a couple who had three recurrent abortions were referred to the Genome laboratory of Isfahan in Iran. Pathological, immunological and hormonal tests were requested for the mother in the first stage, and also Giemsa banding karyotype were requested for the father and mother. Next, array comparative genomic hybridization (array CGH) was requested for the aborted fetus sampling, and whole-exome sequencing was done to mutation analysis. Here, for the first time we report a case which contains novel homozygote mutation NM_173660:exon4:c.G481A:p.G161R in DOK7 gene locates on 4p16.3 as a novel mutation of the DOK7 gene that is a pathogenic variant and may play an important role in Fetal akinesia deformation sequence 3. Homozygote mutation NM_173660:exon4:c.G481A:p.G161R in DOK7 gene as a pathogenic variant may play an important role in Fetal akinesia deformation sequence 3 that directly results in recurring miscarriage.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC60 artigos no totalmostrando 65

2026

Whole Genome Sequence Identifies the Second Allele: An Intronic Variant in RYR1 Contributes to Early-Onset Fetal Akinesia Deformation Sequence.

Molecular syndromology
2026

Preemptive immunotherapy for fetal acetylcholine receptor antibody disorder (FARAD): from recurrent pregnancy losses to a healthy infant - a case report.

Neuromuscular disorders : NMD
2026

Variant Update on ASCC1 : Characterization of the First Homozygous Missense Variant Involved in Prenatal-Onset Spinal Muscular Atrophy With Congenital Bone Fractures 2.

American journal of medical genetics. Part A
2025

DOK7 Gene Novel Homozygous Mutation is Related to Fetal Akinesia Deformation Sequence 3.

Journal of obstetrics and gynaecology of India
2025

The evolving genetic landscape of neuromuscular fetal akinesias.

Journal of neuromuscular diseases
2025

Biallelic Variant, c.644-13_644-9del in UNC50 Is Associated With Congenital Myasthenia Syndrome.

American journal of medical genetics. Part A
2026

Perinatal genetic diagnostic yield in a population of fetuses with the phenotype arthrogryposis multiplex congenita: a cohort study 2007-2021.

European journal of human genetics : EJHG
2025

Biallelic variants in AGRN in a family with recurrent pregnancy losses and fetal akinesia deformation sequence.

Clinical dysmorphology
2025

Identification of a Founder GLDN Variant Associated With "Lethal" Arthrogryposis in Nunavik Inuit: Implications for Obstetrical and Long-Term Survivors' Management.

American journal of medical genetics. Part A
2024

The p.R66W Variant in RAC3 Causes Severe Fetopathy Through Variant-Specific Mechanisms.

Cells
2025

ECEL1 mutation in distal arthrogryposis type 5D: A case report.

European journal of obstetrics, gynecology, and reproductive biology
2024

Identification of four TTN variants in three families with fetal akinesia deformation sequence.

BMC medical genomics
2024

Novel variant in ACTA1 identified in a fetus with akinesia deformation sequence and cortical development delay.

Prenatal diagnosis
2024

The severity of MUSK pathogenic variants is predicted by the protein domain they disrupt.

HGG advances
2024

Clinical and molecular characteristics of 26 fetuses with lethal multiple congenital contractures.

Clinical genetics
2024

Alteration of actin cytoskeletal organisation in fetal akinesia deformation sequence.

Scientific reports
2023

Biallellic variants in CACNA1S cause fetal akinesia sequence, progressive hydrops and stillbirth.

Prenatal diagnosis
2024

Severe neuromuscular forms of glycogen storage disease type IV: Histological, clinical, biochemical, and molecular findings in a large French case series.

Journal of inherited metabolic disease
2024

Variants in DOK7 results in fetal akinesia deformation sequence: A case report and review of literature.

Clinical genetics
2023

Fetal akinesia deformation sequence syndrome associated with recessive TTN variants.

American journal of medical genetics. Part A
2023

Clinically diverse and perinatally lethal syndromes with urorectal septum malformation sequence.

American journal of medical genetics. Part A
2022

Restrictive dermopathy: A baby with taut skin, facial dysmorphism, joint contractures, and pulmonary hypoplasia.

JAAD case reports
2022

Lethal Congenital Contracture Syndrome 11: A Case Report and Literature Review.

Journal of clinical medicine
2022

Broadening the phenotypic spectrum of TUBA1A tubulinopathy to syndromic arthrogryposis multiplex congenita.

American journal of medical genetics. Part A
2022

A single center experience of prenatal parent-fetus trio exome sequencing for pregnancies with congenital anomalies.

Prenatal diagnosis
2021

Fetal akinesia deformation sequence and massive perivillous fibrin deposition resulting in fetal death in six fetuses from one consanguineous couple, including literature review.

Molecular genetics &amp; genomic medicine
2021

Fetal akinesia deformation sequence with pontocerebellar hypoplasia, and migration and gyration defects.

Autopsy &amp; case reports
2021

Joint development recovery on resumption of embryonic movement following paralysis.

Disease models &amp; mechanisms
2021

Deformations associated with arthrogryposis.

American journal of medical genetics. Part A
2021

CHRNB1-associated congenital myasthenia syndrome: Expanding the clinical spectrum.

American journal of medical genetics. Part A
2020

Centrosome and ciliary abnormalities in fetal akinesia deformation sequence human fibroblasts.

Scientific reports
2021

Neurogenetic fetal akinesia and arthrogryposis: genetics, expanding genotype-phenotypes and functional genomics.

Journal of medical genetics
2020

The latest FADS: Functional analysis of GLDN patient variants and classification of GLDN-associated AMC as a type of viable fetal akinesia deformation sequence.

American journal of medical genetics. Part A
2020

Biallelic c.1263dupC in DOK7 results in fetal akinesia deformation sequence.

American journal of medical genetics. Part A
2020

Prenatal sonographic diagnosis of Dandy-Walker malformation and type III lissencephaly: A novel association.

Journal of clinical ultrasound : JCU
2019

Compound heterozygous mutation of MUSK causing fetal akinesia deformation sequence syndrome: A case report.

World journal of clinical cases
2020

Null variants in AGRN cause lethal fetal akinesia deformation sequence.

Clinical genetics
2019

Diagnosis of fetal non-chromosomal abnormalities on routine ultrasound examination at 11-13 weeks' gestation.

Ultrasound in obstetrics &amp; gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
2019

Fetal arthrogryposis multiplex congenita/fetal akinesia deformation sequence (FADS)-Aetiology, diagnosis, and management.

Prenatal diagnosis
2019

Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence.

Experimental neurology
2019

SLC18A3 variants lead to fetal akinesia deformation sequence early in pregnancy.

American journal of medical genetics. Part A
2020

Next generation sequencing in recurrent pregnancy loss-approaches and outcomes.

European journal of medical genetics
2019

Isolated vocal cord paralysis in two siblings with compound heterozygous variants in MUSK: Expanding the phenotypic spectrum.

American journal of medical genetics. Part A
2019

Homozygous/compound heterozygote RYR1 gene variants: Expanding the clinical spectrum.

American journal of medical genetics. Part A
2019

Fetal akinesia deformation sequence, arthrogryposis multiplex congenita, and bilateral clubfeet: Is motor assessment of additional value for in utero diagnosis? A 10-year cohort study.

Prenatal diagnosis
2018

Biallelic mutations in nucleoporin NUP88 cause lethal fetal akinesia deformation sequence.

PLoS genetics
2018

Pena-Shokeir syndrome: current management strategies and palliative care.

The application of clinical genetics
2019

Novel pathogenic variants in GBE1 causing fetal akinesia deformation sequence and severe neuromuscular form of glycogen storage disease type IV.

Clinical dysmorphology
2019

Molecular autopsy by trio exome sequencing (ES) and postmortem examination in fetuses and neonates with prenatally identified structural anomalies.

Genetics in medicine : official journal of the American College of Medical Genetics
2017

Appropriate use of next generation sequencing facilities for identifying new genetic causes of fetal akinesia deformation sequence (FADS).

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2017

Massive parallel sequencing identifies RAPSN and PDHA1 mutations causing fetal akinesia deformation sequence.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2017

Lethal multiple pterygium syndrome: A severe phenotype associated with a novel mutation in the nebulin gene.

Neuromuscular disorders : NMD
2017

Mutations in the NEB gene cause fetal akinesia/arthrogryposis multiplex congenita.

Prenatal diagnosis
2016

Type 0 Spinal Muscular Atrophy: Further Delineation of Prenatal and Postnatal Features in 16 Patients.

Journal of neuromuscular diseases
2016

Identification of KLHL40 mutations by targeted next-generation sequencing facilitated a prenatal diagnosis in a family with three consecutive affected fetuses with fetal akinesia deformation sequence.

Prenatal diagnosis
2016

Discordant monoamniotic twins with Pena-Shokeir phenotype.

Clinical case reports
2016

Congenital Zika Virus Infection: Beyond Neonatal Microcephaly.

JAMA neurology
2016

A novel neuromuscular form of glycogen storage disease type IV with arthrogryposis, spinal stiffness and rare polyglucosan bodies in muscle.

Neuromuscular disorders : NMD
2016

Prenatal diagnosis of fetal akinesia deformation sequence (FADS): a study of 79 consecutive cases.

Archives of gynecology and obstetrics
2016

Deficiency of the myogenic factor MyoD causes a perinatally lethal fetal akinesia.

Journal of medical genetics
2016

De novo TUBB2B mutation causes fetal akinesia deformation sequence with microlissencephaly: An unusual presentation of tubulinopathy.

European journal of medical genetics
2015

Exome sequencing positively identified relevant alterations in more than half of cases with an indication of prenatal ultrasound anomalies.

Prenatal diagnosis
2015

Fetal akinesia deformation sequence due to a congenital disorder of glycosylation.

American journal of medical genetics. Part A
2015

Targeted carrier screening for four recessive disorders: high detection rate within a founder population.

European journal of medical genetics
2015

MuSK: a new target for lethal fetal akinesia deformation sequence (FADS).

Journal of medical genetics

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Sequência de deformação de acinesia fetal.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Sequência de deformação de acinesia fetal

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Perinatal genetic diagnostic yield in a population of fetuses with the phenotype arthrogryposis multiplex congenita: a cohort study 2007-2021.
    European journal of human genetics : EJHG· 2026· PMID 40195522mais citado
  2. Whole Genome Sequence Identifies the Second Allele: An Intronic Variant in RYR1 Contributes to Early-Onset Fetal Akinesia Deformation Sequence.
    Molecular syndromology· 2026· PMID 41878156mais citado
  3. Preemptive immunotherapy for fetal acetylcholine receptor antibody disorder (FARAD): from recurrent pregnancy losses to a healthy infant - a case report.
    Neuromuscular disorders : NMD· 2026· PMID 41650630mais citado
  4. Variant Update on ASCC1 : Characterization of the First Homozygous Missense Variant Involved in Prenatal-Onset Spinal Muscular Atrophy With Congenital Bone Fractures 2.
    American journal of medical genetics. Part A· 2026· PMID 41230573mais citado
  5. DOK7 Gene Novel Homozygous Mutation is Related to Fetal Akinesia Deformation Sequence 3.
    Journal of obstetrics and gynaecology of India· 2025· PMID 40390963mais citado
  6. The evolving genetic landscape of neuromuscular fetal akinesias.
    J Neuromuscul Dis· 2025· PMID 40356365recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:994(Orphanet)
  2. OMIM OMIM:208150(OMIM)
  3. MONDO:0100101(MONDO)
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q54366512(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Sequência de deformação de acinesia fetal
Compêndio · Raras BR

Sequência de deformação de acinesia fetal

ORPHA:994 · MONDO:0100101
Prevalência
<1 / 1 000 000
Herança
Autosomal recessive
CID-10
Q87.8 · Outras síndromes com malformações congênitas especificadas, não classificadas em outra parte
CID-11
Início
Antenatal, Neonatal
Prevalência
0.0 (Europe)
MedGen
UMLS
C1276035
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades